title: [Possible pharmacological correction of metabolic impairments experimental diabetes mellitus by antioxidant].
abstract: On model of experimental diabetes in rats the possibility of correction of impairments of lipid, carbohydrate and albumin metabolism by SEMOP in a dose of 25 or 5 mg/kg, dimephosphone (100 mg/kg) and alpha-tocopherol (25 mg/kg) has been Advantage of SEMOP consists in its ability to decrease a level of total protein and albumin of blood of animals with experimental diabetes.
authors.forename: L D
authors.initials: LD
authors.lastname: Smirnov
authors.forename: V I
authors.initials: VI
authors.lastname: Inchina
authors.forename: Ia V
authors.initials: IaV
authors.lastname: Kostin
authors.forename: E V
authors.initials: EV
authors.lastname: Kokoreva
authors.forename: Zh V
authors.initials: ZhV
authors.lastname: Bogoliubova
mesh_terms: D000418:Albumins / Q000378:metabolism; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D050260:Carbohydrate Metabolism; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D050356:Lipid Metabolism; D015227:Lipid Peroxidation; D008297:Male; D051381:Rats
chemical_list: D000418:Albumins; D000975:Antioxidants